QLIF-17. ASSESSING DEPRESSION IN GLIOMA PATIENTS

BACKGROUND: A recent Cochrane review revealed only 5 studies exploring depression in glioma patients with variable incidence of 17% to as high as 49%; and even fewer studies using instruments designed to measure depression severity and therapeutic approaches. METHODS: Patients enrolled in the Neuro-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Acquaye, Alvina A, Garren, Nancy, Vera, Elizabeth, Lisa, Boris, Siegel, Christine, Park, Deric M, Wu, Jing, Crandon, Sonja, Theeler, Brett J, Sul, Joo-Hee, Gilbert, Mark R, Armstrong, Terri
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692376/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.827
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares